4aze

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
{{STRUCTURE_4aze| PDB=4aze | SCENE= }}
+
==Human DYRK1A in complex with Leucettine L41==
-
===Human DYRK1A in complex with Leucettine L41===
+
<StructureSection load='4aze' size='340' side='right' caption='[[4aze]], [[Resolution|resolution]] 3.15&Aring;' scene=''>
-
{{ABSTRACT_PUBMED_22998443}}
+
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[4aze]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AZE OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4AZE FirstGlance]. <br>
 +
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=3RA:5-(1,3-BENZODIOXOL-5-YLMETHYL)-2-(PHENYLAMINO)-4H-IMIDAZOL-4-ONE'>3RA</scene></td></tr>
 +
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=PTR:O-PHOSPHOTYROSINE'>PTR</scene>, <scene name='pdbligand=SEP:PHOSPHOSERINE'>SEP</scene>, <scene name='pdbligand=UNK:UNKNOWN'>UNK</scene></td></tr>
 +
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2vx3|2vx3]], [[2wo6|2wo6]], [[4azf|4azf]]</td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4aze FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4aze OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4aze RCSB], [http://www.ebi.ac.uk/pdbsum/4aze PDBsum]</span></td></tr>
 +
</table>
 +
== Disease ==
 +
[[http://www.uniprot.org/uniprot/DYR1A_HUMAN DYR1A_HUMAN]] Defects in DYRK1A are the cause of mental retardation autosomal dominant type 7 (MRD7) [MIM:[http://omim.org/entry/614104 614104]]. A disease characterized by primary microcephaly, severe mental retardation without speech, anxious autistic behavior, and dysmorphic features, including bitemporal narrowing, deep-set eyes, large simple ears, and a pointed nasal tip. Mental retardation is characterized by significantly below average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period.<ref>PMID:21294719</ref>
 +
== Function ==
 +
[[http://www.uniprot.org/uniprot/DYR1A_HUMAN DYR1A_HUMAN]] May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates.<ref>PMID:8769099</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
DYRKs (dual specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) are implicated in the onset and development of Alzheimer's disease and Down syndrome. The marine sponge alkaloid Leucettamine B was recently identified as an inhibitor of DYRKs/CLKs. Synthesis of analogues (Leucettines) led to an optimized product, Leucettine L41. Leucettines were co-crystallized with DYRK1A, DYRK2, CLK3, PIM1 and GSK-3beta. The selectivity of L41 was studied by activity &amp; interaction assays of recombinant kinases and affinity chromatography &amp; competition affinity assays. These approaches revealed unexpected potential secondary targets such as CK2, SLK and the lipid kinase PIKfyve/Vac14/Fig4. L41 displayed neuroprotective effects on glutamate-induced HT22 cell death. L41 also reduced amyloid precursor protein -induced cell death in cultured rat brain slices. The unusual multi-target selectivity of Leucettines may account for their neuroprotective effects. This family of kinase inhibitors deserves further optimization as potential therapeutics against neurodegenerative diseases such as Alzheimer's disease.
-
==Disease==
+
Selectivity, co-crystal structures and neuroprotective properties of Leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid Leucettamine B.,Tahtouh T, Elkins JM, Filippakopoulos P, Soundararajan M, Burgy G, Durieu E, Cochet C, Schmid R, Lo D, Delhommel F, Oberholzer A, Laurence P, Carreaux F, Bazureau JP, Knapp S, Meijer L J Med Chem. 2012 Sep 21. PMID:22998443<ref>PMID:22998443</ref>
-
[[http://www.uniprot.org/uniprot/DYR1A_HUMAN DYR1A_HUMAN]] Defects in DYRK1A are the cause of mental retardation autosomal dominant type 7 (MRD7) [MIM:[http://omim.org/entry/614104 614104]]. A disease characterized by primary microcephaly, severe mental retardation without speech, anxious autistic behavior, and dysmorphic features, including bitemporal narrowing, deep-set eyes, large simple ears, and a pointed nasal tip. Mental retardation is characterized by significantly below average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period.<ref>PMID:21294719</ref>
+
-
==Function==
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
[[http://www.uniprot.org/uniprot/DYR1A_HUMAN DYR1A_HUMAN]] May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates.<ref>PMID:8769099</ref>
+
</div>
-
 
+
== References ==
-
==About this Structure==
+
<references/>
-
[[4aze]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AZE OCA].
+
__TOC__
-
 
+
</StructureSection>
-
==Reference==
+
-
<references group="xtra"/><references/>
+
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
-
[[Category: Bazureau, J P.]]
+
[[Category: Bazureau, J P]]
-
[[Category: Bountra, C.]]
+
[[Category: Bountra, C]]
-
[[Category: Burgy, G.]]
+
[[Category: Burgy, G]]
-
[[Category: Carreaux, F.]]
+
[[Category: Carreaux, F]]
-
[[Category: Cochet, C.]]
+
[[Category: Cochet, C]]
-
[[Category: Delhommel, F.]]
+
[[Category: Delhommel, F]]
-
[[Category: Durieu, E.]]
+
[[Category: Durieu, E]]
-
[[Category: Edwards, A.]]
+
[[Category: Edwards, A]]
-
[[Category: Elkins, J M.]]
+
[[Category: Elkins, J M]]
-
[[Category: Knapp, S.]]
+
[[Category: Knapp, S]]
-
[[Category: Lo, D C.]]
+
[[Category: Lo, D C]]
-
[[Category: Lozach, O.]]
+
[[Category: Lozach, O]]
-
[[Category: Meijer, L.]]
+
[[Category: Meijer, L]]
-
[[Category: Muniz, J R.C.]]
+
[[Category: Muniz, J R.C]]
-
[[Category: Schmid, R S.]]
+
[[Category: Schmid, R S]]
-
[[Category: Soundararajan, M.]]
+
[[Category: Soundararajan, M]]
-
[[Category: Tahtouh, T.]]
+
[[Category: Tahtouh, T]]
[[Category: Transferase]]
[[Category: Transferase]]

Revision as of 10:01, 21 December 2014

Human DYRK1A in complex with Leucettine L41

4aze, resolution 3.15Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/4aze"
Personal tools